首页 > 最新文献

South Asian Journal of Cancer最新文献

英文 中文
Knowledge and Attitude of Cervical Cancer Screening and Vaccination in Patients Attending Gynecology Outpatient Clinic at a Tertiary Care Hospital in Pakistan. 巴基斯坦某三级医院妇科门诊患者宫颈癌筛查和疫苗接种的知识和态度
IF 0.5 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1055/s-0042-1751093
Shamaila Shamaun, Riffat Jaleel, Yasmeen Gull, Afshan Shahid, Mehreen Iqbal, Tabinda Naseer Qazi

Shamaila ShamaunBackground  Cervical cancer is the third most prevalent female cancer in Pakistan; nearly 70% present at a very advanced stage of malignancy due to lack of awareness, proper screening, and vaccination. Therefore, we aimed to assess the knowledge and attitude toward screening, vaccination, and risk factors of cervical cancer in sexually active women of Pakistan. Methods  This cross-sectional study was conducted at the gynecology outpatient clinic of a public sector hospital in Karachi, Pakistan, from December 2021 to March 2022. We included sexually active women with exception of diagnosed cases of cervical cancer, pregnancy, vaginal bleeding, and psychological disorder. Collected data were regarding demographic characteristics, awareness regarding cervical cancer, screening, human papillomavirus (HPV) vaccine, and risk factors, history of cervical screening, and wiliness to opt-in for cervical screening. Results  We included 226 women with a mean age of 41.25 ± 10.54 years. The mean parity level was observed to be 3.8 ± 1.95. A majority of women were housewives by profession (88.9%) and uneducated (61.9%). Only 41.2% (93) of women were aware of cervical cancer, 33.6% (76) were aware of cervical screening, and only 15.9% (36) had a history of cervical screening. Only four women (1.8%) were aware of the HPV vaccine and 31% (70) showed intention to opt-in for cervical screening. A vast majority of women (96.9%) were not aware of the risk factors of cervical cancer. Conclusion(s)  We have observed poor awareness regarding cervical cancer, HPV vaccination, and cervical screening among women in our population. Lack of awareness was not restricted to a certain segment but it prevails all across the demographic in our population.

背景:子宫颈癌是巴基斯坦第三大流行的女性癌症;由于缺乏意识、适当的筛查和疫苗接种,近70%的恶性肿瘤处于非常晚期。因此,我们的目的是评估巴基斯坦性活跃妇女对宫颈癌筛查、疫苗接种和危险因素的知识和态度。方法本横断面研究于2021年12月至2022年3月在巴基斯坦卡拉奇一家公立医院妇科门诊进行。我们纳入了性活跃的女性,但诊断为宫颈癌、怀孕、阴道出血和心理障碍的病例除外。收集的数据包括人口统计学特征、对宫颈癌的认识、筛查、人乳头瘤病毒(HPV)疫苗、危险因素、宫颈筛查史以及选择接受宫颈筛查的意愿。结果纳入226例女性,平均年龄41.25±10.54岁。平均胎次水平为3.8±1.95。大多数妇女的职业是家庭主妇(88.9%)和未受教育(61.9%)。仅有41.2%(93人)的女性知道宫颈癌,33.6%(76人)的女性知道宫颈筛查,仅有15.9%(36人)有宫颈筛查史。只有4名妇女(1.8%)知道HPV疫苗,31%(70)表示有意选择宫颈筛查。绝大多数妇女(96.9%)不知道宫颈癌的危险因素。结论:我们观察到我国人口中妇女对宫颈癌、HPV疫苗接种和子宫颈筛查的认识较差。缺乏意识并不局限于某一部分人,而是在我们的人口中普遍存在。
{"title":"Knowledge and Attitude of Cervical Cancer Screening and Vaccination in Patients Attending Gynecology Outpatient Clinic at a Tertiary Care Hospital in Pakistan.","authors":"Shamaila Shamaun,&nbsp;Riffat Jaleel,&nbsp;Yasmeen Gull,&nbsp;Afshan Shahid,&nbsp;Mehreen Iqbal,&nbsp;Tabinda Naseer Qazi","doi":"10.1055/s-0042-1751093","DOIUrl":"https://doi.org/10.1055/s-0042-1751093","url":null,"abstract":"<p><p>Shamaila Shamaun<b>Background</b>  Cervical cancer is the third most prevalent female cancer in Pakistan; nearly 70% present at a very advanced stage of malignancy due to lack of awareness, proper screening, and vaccination. Therefore, we aimed to assess the knowledge and attitude toward screening, vaccination, and risk factors of cervical cancer in sexually active women of Pakistan. <b>Methods</b>  This cross-sectional study was conducted at the gynecology outpatient clinic of a public sector hospital in Karachi, Pakistan, from December 2021 to March 2022. We included sexually active women with exception of diagnosed cases of cervical cancer, pregnancy, vaginal bleeding, and psychological disorder. Collected data were regarding demographic characteristics, awareness regarding cervical cancer, screening, human papillomavirus (HPV) vaccine, and risk factors, history of cervical screening, and wiliness to opt-in for cervical screening. <b>Results</b>  We included 226 women with a mean age of 41.25 ± 10.54 years. The mean parity level was observed to be 3.8 ± 1.95. A majority of women were housewives by profession (88.9%) and uneducated (61.9%). Only 41.2% (93) of women were aware of cervical cancer, 33.6% (76) were aware of cervical screening, and only 15.9% (36) had a history of cervical screening. Only four women (1.8%) were aware of the HPV vaccine and 31% (70) showed intention to opt-in for cervical screening. A vast majority of women (96.9%) were not aware of the risk factors of cervical cancer. <b>Conclusion(s)</b>  We have observed poor awareness regarding cervical cancer, HPV vaccination, and cervical screening among women in our population. Lack of awareness was not restricted to a certain segment but it prevails all across the demographic in our population.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"17-22"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f6/0e/10-1055-s-0042-1751093.PMC9966166.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10813463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship between Gynecological Cancer Awareness and Self-Care Agency in Married Women. 已婚妇女妇科癌症意识与自我保健能动性的关系
IF 0.5 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1055/s-0042-1754344
Nursel Alp Dal, K Derya Beydağ, Özlem Ikde Öner

Nursel Alp DalObjective  This study was conducted to determine the relationship between gynecological cancer awareness and self-care agency among married women. Materials and Methods  This descriptive and cross-sectional study was performed with 819 women who presented to the obstetrics polyclinic of a hospital located in the west of Turkey between December 15, 2020 and April 15, 2021. The data of the study were collected by using the Exercise of Self-Care Agency Scale (ESCA) and the Gynecological Cancers Awareness Scale (GCAS). Results  The mean age of the participants was 37.62 ± 9.181 years. The mean ESCA score of the women who participated in this study was 95.89 ± 25.060, which indicated moderate levels of self-care agency. The mean total GCAS score of the participants of this study was 156.57 ± 32.930, which indicated high levels of gynecological cancer awareness among the women. As the self-care agency of the women increased, their awareness of gynecological cancers also increased. Conclusion  Midwives and nurses who provide preventive and supportive healthcare services may affect the self-care agency of women positively by gynecological cancer awareness they will raise in these women.

目的探讨已婚妇女妇科癌症意识与自我保健能动性的关系。材料和方法本描述性和横断面研究对2020年12月15日至2021年4月15日期间在土耳其西部一家医院产科综合诊所就诊的819名妇女进行了研究。本研究采用自我护理代理量表(ESCA)和妇科癌症认知量表(GCAS)收集资料。结果患者平均年龄为37.62±9.181岁。参与本研究的女性ESCA平均得分为95.89±25.060,自我照顾代理水平中等。研究对象的GCAS平均总分为156.57±32.930,表明女性对妇科肿瘤的认知水平较高。随着女性自我保健能力的提高,她们对妇科癌症的认识也在提高。结论提供预防性和支持性保健服务的助产士和护士可通过提高妇女的妇科癌症意识,对妇女的自我保健能力产生积极影响。
{"title":"The Relationship between Gynecological Cancer Awareness and Self-Care Agency in Married Women.","authors":"Nursel Alp Dal,&nbsp;K Derya Beydağ,&nbsp;Özlem Ikde Öner","doi":"10.1055/s-0042-1754344","DOIUrl":"https://doi.org/10.1055/s-0042-1754344","url":null,"abstract":"<p><p>Nursel Alp Dal<b>Objective</b>  This study was conducted to determine the relationship between gynecological cancer awareness and self-care agency among married women. <b>Materials and Methods</b>  This descriptive and cross-sectional study was performed with 819 women who presented to the obstetrics polyclinic of a hospital located in the west of Turkey between December 15, 2020 and April 15, 2021. The data of the study were collected by using the Exercise of Self-Care Agency Scale (ESCA) and the Gynecological Cancers Awareness Scale (GCAS). <b>Results</b>  The mean age of the participants was 37.62 ± 9.181 years. The mean ESCA score of the women who participated in this study was 95.89 ± 25.060, which indicated moderate levels of self-care agency. The mean total GCAS score of the participants of this study was 156.57 ± 32.930, which indicated high levels of gynecological cancer awareness among the women. As the self-care agency of the women increased, their awareness of gynecological cancers also increased. <b>Conclusion</b>  Midwives and nurses who provide preventive and supportive healthcare services may affect the self-care agency of women positively by gynecological cancer awareness they will raise in these women.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"30-35"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fc/7a/10-1055-s-0042-1754344.PMC9966168.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10813469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical Outcomes of Uterine Body Cancers Treated in a Tertiary Cancer Center. 某三级肿瘤中心治疗子宫体癌的临床效果。
IF 0.5 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1055/s-0042-1757550
K Muthulingeshkumar, Jagadesan Pandjatcharam, Latha Chaturvedula

K. MuthulingeshkumarObjectives  This article reports the clinical outcomes of uterine body cancers in South Indian population. The primary outcome of our study was overall survival (OS). The secondary outcomes were disease-free survival (DFS), patterns of recurrence, toxicities of radiation treatment, and the association of patient, disease, and treatment characteristics with survival and recurrence. Materials and Methods  Records of the patients diagnosed as malignancy in uterus and treated with surgery alone or with adjuvant treatment from January 2013 to December 2017 were retrieved after Institute Ethics Committee approval. Demographic, surgical, histopathology, and adjuvant treatment details were retrieved. Patients of endometrial adenocarcinoma were stratified according to the European Society of Medical Oncology/European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology consensus for analysis and overall outcomes irrespective of histology were also analyzed. Statistical Analysis  For the survival analysis, Kaplan-Meier survival estimator was used. Cox regression was used to test the significance of association of factors with outcomes in terms of hazard ratio (HR). Results  A total of 178 patient records were retrieved. The median follow-up of all patients was 30 months (0.5-81 months). The median age of the population was 55 years. Most common histology was endometrioid type of adenocarcinoma (89%), sarcomas comprised only 4%. The mean OS of all patients was 68 months ( n  = 178), median was not reached. Five-year OS was 79 %. Five-year OS rates observed in low, intermediate, high-intermediate, and high-risk were 91, 88, 75, and 81.5%, respectively. The mean DFS was 65 months, median not reached. The 5-year DFS was 76%. The 5-year DFS rates observed were 82, 95, 80, and 81.5% for low, intermediate, high-intermediate, and high-risk, respectively. Univariate analysis using Cox regression showed increase in hazard for death in case of node positivity, HR 3.96 ( p 0.033). The HR for disease recurrence was 0.35 ( p  = 0.042) in patients who had received adjuvant radiation therapy. No other factors had any significant impact on death or disease recurrence. Conclusion  The survival outcomes in terms of DFS and OS were comparable with other Indian and Western data reported in the published literature.

目的报道南印度人群子宫体癌的临床结果。我们研究的主要终点是总生存期(OS)。次要结果是无病生存期(DFS)、复发模式、放射治疗的毒性,以及患者、疾病和治疗特征与生存和复发的关系。材料与方法检索我院2013年1月至2017年12月诊断为子宫恶性肿瘤且单独手术或辅助治疗的患者记录,经我院伦理委员会批准。检索了人口统计学、外科、组织病理学和辅助治疗的细节。根据欧洲肿瘤医学学会/欧洲妇科肿瘤学会/欧洲放射治疗和肿瘤学会的共识对子宫内膜腺癌患者进行分层分析,并对不考虑组织学的总体结果进行分析。统计学分析生存分析采用Kaplan-Meier生存估计。采用Cox回归以风险比(HR)检验各因素与结局相关的显著性。结果共检索到178例患者病历。所有患者的中位随访时间为30个月(0.5 ~ 81个月)。人口的中位年龄为55岁。最常见的组织学为子宫内膜样腺癌(89%),肉瘤仅占4%。所有患者的平均OS为68个月(n = 178),未达到中位数。5年生存率为79%。低、中、高、中、高风险组的5年总生存率分别为91%、88%、75%和81.5%。平均生存期为65个月,中位数未达到。5年DFS为76%。低、中、高、中、高风险组的5年DFS分别为82%、95.5%、80%和81.5%。单因素Cox回归分析显示,淋巴结阳性患者死亡风险增加,相对危险度为3.96 (p 0.033)。接受辅助放疗的患者疾病复发的HR为0.35 (p = 0.042)。没有其他因素对死亡或疾病复发有显著影响。结论在DFS和OS方面的生存结果与其他印度和西方已发表的文献报道的数据相当。
{"title":"Clinical Outcomes of Uterine Body Cancers Treated in a Tertiary Cancer Center.","authors":"K Muthulingeshkumar,&nbsp;Jagadesan Pandjatcharam,&nbsp;Latha Chaturvedula","doi":"10.1055/s-0042-1757550","DOIUrl":"https://doi.org/10.1055/s-0042-1757550","url":null,"abstract":"<p><p>K. Muthulingeshkumar<b>Objectives</b>  This article reports the clinical outcomes of uterine body cancers in South Indian population. The primary outcome of our study was overall survival (OS). The secondary outcomes were disease-free survival (DFS), patterns of recurrence, toxicities of radiation treatment, and the association of patient, disease, and treatment characteristics with survival and recurrence. <b>Materials and Methods</b>  Records of the patients diagnosed as malignancy in uterus and treated with surgery alone or with adjuvant treatment from January 2013 to December 2017 were retrieved after Institute Ethics Committee approval. Demographic, surgical, histopathology, and adjuvant treatment details were retrieved. Patients of endometrial adenocarcinoma were stratified according to the European Society of Medical Oncology/European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology consensus for analysis and overall outcomes irrespective of histology were also analyzed. <b>Statistical Analysis</b>  For the survival analysis, Kaplan-Meier survival estimator was used. Cox regression was used to test the significance of association of factors with outcomes in terms of hazard ratio (HR). <b>Results</b>  A total of 178 patient records were retrieved. The median follow-up of all patients was 30 months (0.5-81 months). The median age of the population was 55 years. Most common histology was endometrioid type of adenocarcinoma (89%), sarcomas comprised only 4%. The mean OS of all patients was 68 months ( <i>n</i>  = 178), median was not reached. Five-year OS was 79 %. Five-year OS rates observed in low, intermediate, high-intermediate, and high-risk were 91, 88, 75, and 81.5%, respectively. The mean DFS was 65 months, median not reached. The 5-year DFS was 76%. The 5-year DFS rates observed were 82, 95, 80, and 81.5% for low, intermediate, high-intermediate, and high-risk, respectively. Univariate analysis using Cox regression showed increase in hazard for death in case of node positivity, HR 3.96 ( <i>p</i> 0.033). The HR for disease recurrence was 0.35 ( <i>p</i>  = 0.042) in patients who had received adjuvant radiation therapy. No other factors had any significant impact on death or disease recurrence. <b>Conclusion</b>  The survival outcomes in terms of DFS and OS were comparable with other Indian and Western data reported in the published literature.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"87-92"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/73/05/10-1055-s-0042-1757550.PMC9970755.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9368926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical Cancer HPV Vaccination and Bhutan. 宫颈癌HPV疫苗接种与不丹。
IF 0.5 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1055/s-0043-1764220
Sachin Hingmire, Ugyen Tshomo, Tashi Dendrup, Amol Patel, Purvish Parikh
1Department of Medical Oncology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India 2Department of Gynecology and Surgical Oncology, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan 3Department of Medical Oncology, INHS Asvini, Colaba, Mumbai, Maharashtra, India 4Department of Clinical Hematology, Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, India
{"title":"Cervical Cancer HPV Vaccination and Bhutan.","authors":"Sachin Hingmire,&nbsp;Ugyen Tshomo,&nbsp;Tashi Dendrup,&nbsp;Amol Patel,&nbsp;Purvish Parikh","doi":"10.1055/s-0043-1764220","DOIUrl":"https://doi.org/10.1055/s-0043-1764220","url":null,"abstract":"1Department of Medical Oncology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India 2Department of Gynecology and Surgical Oncology, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan 3Department of Medical Oncology, INHS Asvini, Colaba, Mumbai, Maharashtra, India 4Department of Clinical Hematology, Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, India","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"41-43"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/73/92/10-1055-s-0043-1764220.PMC9970746.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9368933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gender Parity in Healthcare: A Chronicle of Escalating Success Rate of Female Radiation Oncologists in India. 医疗保健中的性别平等:印度女性放射肿瘤学家成功率上升的编年史
IF 0.5 Q4 ONCOLOGY Pub Date : 2022-12-31 eCollection Date: 2023-10-01 DOI: 10.1055/s-0042-1756631
Biplab Sarkar, Anirudh Pradhan

Biplab SarkarObjectives  This editorial describes the growth pattern of female radiation oncologists (FRO) in India and the prediction of gender equality through a mathematical formulation. Materials and Methods  Among the countries in South Asia, India has the largest population of radiation oncologists (RO), a total of 3,763: 1,286 female and 2,477 male radiation oncologists (MROs), and they are registered with the Association of Radiation Oncologists of India (AROI). The data were analyzed to find the differential and cumulative growth pattern of the FROs and MROs and predict gender equality in radiation oncology. The cumulative growth rate indicates the total number of FROs and MROs by end of every year. Differential growth rate indicates the differential increase in the number of FROs and MROs for a particular year. Annual cumulative and differential growth patterns were plotted as a function of the time, and an analytical functional form was fitted to predict the future growth pattern and achievement of gender equality. Results  AROI registration of FROs and MROs for 2013-2020 were as follows: FRO: MRO 2013-54: 102, 2014-99: 162, 2015-77: 148; 2016-86: 143, 2017-110: 110, 2018-116: 151, 2019-121: 152, 2020 (October)-129: 110. Differential growth pattern between 2013 and 2020 with the average incremental growth rate for FROs and MROs were 12.7 ± 14.8% and 2.1 ± 32.0%. Differential growth rate FRO fits in a power-law exponent 58.6 ×(Power0.3695), where MRO growth pattern showed a saturation [4.7ln(×) + 128.5] . Gender parity among Indian radiation oncologists is likely to be achieved by end of 2027. Conclusions  The present density of FRO in India 34.1% is high compared to developed countries such as the United States (≈26%). It is a big leap for the Indian radiation oncology society tending toward gender parity.

这篇社论描述了印度女性放射肿瘤学家(FRO)的增长模式,并通过数学公式预测性别平等。在南亚国家中,印度拥有最多的放射肿瘤学家(RO),共有3,763人,其中女性1,286人,男性2,477人,他们在印度放射肿瘤学家协会(AROI)注册。对数据进行分析,发现FROs和mro的差异和累积生长模式,并预测放射肿瘤学中的性别平等。累计增长率表示到每年年底froo和mro的总数。差异增长率表示某一特定年份froo和mro数量的差异增长。将年度累积和差异增长模式绘制为时间的函数,并拟合分析函数形式来预测未来的增长模式和性别平等的实现。结果2013-2020年FRO和MRO的AROI配准情况为:FRO: MRO 2013- 54,102, 2014-99: 162, 2015-77: 148;2016-86: 143、2017-110:110、2018-116:151、2019-121:152、2020(10月)-129:110。2013 - 2020年的增长格局差异,FROs和mro的平均增量增长率分别为12.7±14.8%和2.1±32.0%。差分生长速率FRO符合幂律指数58.6 ×(Power0.3695),其中MRO生长模式呈现饱和[4.7ln(x) + 128.5]。到2027年底,印度放射肿瘤学家的性别平等可能会实现。结论目前印度FRO的密度为34.1%,高于美国等发达国家(≈26%)。这是印度放射肿瘤学协会迈向性别平等的一大飞跃。
{"title":"Gender Parity in Healthcare: A Chronicle of Escalating Success Rate of Female Radiation Oncologists in India.","authors":"Biplab Sarkar, Anirudh Pradhan","doi":"10.1055/s-0042-1756631","DOIUrl":"10.1055/s-0042-1756631","url":null,"abstract":"<p><p>Biplab Sarkar<b>Objectives</b>  This editorial describes the growth pattern of female radiation oncologists (FRO) in India and the prediction of gender equality through a mathematical formulation. <b>Materials and Methods</b>  Among the countries in South Asia, India has the largest population of radiation oncologists (RO), a total of 3,763: 1,286 female and 2,477 male radiation oncologists (MROs), and they are registered with the Association of Radiation Oncologists of India (AROI). The data were analyzed to find the differential and cumulative growth pattern of the FROs and MROs and predict gender equality in radiation oncology. The cumulative growth rate indicates the total number of FROs and MROs by end of every year. Differential growth rate indicates the differential increase in the number of FROs and MROs for a particular year. Annual cumulative and differential growth patterns were plotted as a function of the time, and an analytical functional form was fitted to predict the future growth pattern and achievement of gender equality. <b>Results</b>  AROI registration of FROs and MROs for 2013-2020 were as follows: FRO: MRO 2013-54: 102, 2014-99: 162, 2015-77: 148; 2016-86: 143, 2017-110: 110, 2018-116: 151, 2019-121: 152, 2020 (October)-129: 110. Differential growth pattern between 2013 and 2020 with the average incremental growth rate for FROs and MROs were 12.7 ± 14.8% and 2.1 ± 32.0%. Differential growth rate FRO fits in a power-law exponent 58.6 ×(Power0.3695), where MRO growth pattern showed a saturation [4.7ln(×) + 128.5] . Gender parity among Indian radiation oncologists is likely to be achieved by end of 2027. <b>Conclusions</b>  The present density of FRO in India 34.1% is high compared to developed countries such as the United States (≈26%). It is a big leap for the Indian radiation oncology society tending toward gender parity.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"1 1","pages":"311-313"},"PeriodicalIF":0.5,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10733059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41476517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer? 新辅助化疗后最佳细胞减少是晚期癌症唯一的预后因素吗?
IF 0.6 Q4 ONCOLOGY Pub Date : 2022-12-30 eCollection Date: 2022-07-01 DOI: 10.1055/s-0042-1755291
Pravesh Dhiman, P P Bapsy, C N Patil, Renu Raghupathi

Pravesh Dhiman, DNB (Medical Oncology).Background  Epithelial ovarian cancer (EOC) is one of the leading causes of cancer-related death in women. Approximately 70% of patients with EOC are diagnosed in advanced stage [The International Federation of Gynecology and Obstetrics(FIGO stage III and IV)] with an expected 5-year survival rate of 30%. Numerous studies have shown that survival with neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) is noninferior to primary debulking surgery followed by chemotherapy. Materials and Methods  In this retroprospective observational study, 50 patients with advanced ovarian cancer, diagnosed from January 2012 to January 2015, were included and followed-up till January 2017. Correlation of NACT with patient profile, CA125 levels, clinicopathologic parameters, progression-free survival (PFS), and treatment response was studied. Statistical analysis was performed using log-rank test and Kaplan-Meir survival plots. Results  The extent of cytoreduction significantly correlated with PFS. The PFS was maximum in patients who had optimal cytoreduction (19 months) and 10 months in patients with suboptimal cytoreduction with p -value < 0.05. The survival was not significantly correlated with other parameters such as age, stage, preoperative CA125 levels, and ascites. Conclusions  The extent of cytoreduction following NACT in this study was associated with statistically significant PFS advantage in patients who were able to undergo optimal cytoreduction, but not significantly correlated to other factors such as age, stage, preoperative CA125 levels, and ascites. NACT followed by interval cytoreduction is an important modality affecting survival in advanced EOC. Further studies and longer follow-up are needed to demonstrate survival advantage over standard treatment.

Pravesh Dhiman,DNB(医学肿瘤学)。背景 癌症上皮癌(EOC)是女性癌症相关死亡的主要原因之一。约70%的EOC患者被诊断为晚期[国际妇产科联合会(FIGO III期和IV期)],预计5年生存率为30%。大量研究表明,新辅助化疗(NACT)后进行间隔性减瘤手术(IDS)的生存率不低于原发性减瘤术后进行化疗。材料和方法 在这项回顾性前瞻性观察性研究中,纳入了2012年1月至2015年1月诊断为晚期癌症的50名患者,并随访至2017年1月。研究了NACT与患者概况、CA125水平、临床病理参数、无进展生存期(PFS)和治疗反应的相关性。使用对数秩检验和Kaplan-Meir生存图进行统计分析。后果 细胞减少程度与PFS显著相关。PFS在具有最佳细胞减少(19个月)的患者中最大,在具有p值的次优细胞减少的患者中为10个月 结论 在本研究中,NACT后的细胞减少程度与能够进行最佳细胞减少的患者具有统计学意义的PFS优势相关,但与年龄、分期、术前CA125水平和腹水等其他因素无关。NACT后间隔细胞减少是影响晚期EOC生存的一种重要方式。需要进一步的研究和更长的随访来证明与标准治疗相比的生存优势。
{"title":"Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?","authors":"Pravesh Dhiman, P P Bapsy, C N Patil, Renu Raghupathi","doi":"10.1055/s-0042-1755291","DOIUrl":"10.1055/s-0042-1755291","url":null,"abstract":"<p><p>Pravesh Dhiman, DNB (Medical Oncology).<b>Background</b>  Epithelial ovarian cancer (EOC) is one of the leading causes of cancer-related death in women. Approximately 70% of patients with EOC are diagnosed in advanced stage [The International Federation of Gynecology and Obstetrics(FIGO stage III and IV)] with an expected 5-year survival rate of 30%. Numerous studies have shown that survival with neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) is noninferior to primary debulking surgery followed by chemotherapy. <b>Materials and Methods</b>  In this retroprospective observational study, 50 patients with advanced ovarian cancer, diagnosed from January 2012 to January 2015, were included and followed-up till January 2017. Correlation of NACT with patient profile, CA125 levels, clinicopathologic parameters, progression-free survival (PFS), and treatment response was studied. Statistical analysis was performed using log-rank test and Kaplan-Meir survival plots. <b>Results</b>  The extent of cytoreduction significantly correlated with PFS. The PFS was maximum in patients who had optimal cytoreduction (19 months) and 10 months in patients with suboptimal cytoreduction with <i>p</i> -value < 0.05. The survival was not significantly correlated with other parameters such as age, stage, preoperative CA125 levels, and ascites. <b>Conclusions</b>  The extent of cytoreduction following NACT in this study was associated with statistically significant PFS advantage in patients who were able to undergo optimal cytoreduction, but not significantly correlated to other factors such as age, stage, preoperative CA125 levels, and ascites. NACT followed by interval cytoreduction is an important modality affecting survival in advanced EOC. Further studies and longer follow-up are needed to demonstrate survival advantage over standard treatment.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"11 3","pages":"207-212"},"PeriodicalIF":0.6,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10289404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Driver Mutations in Lung Cancer-Mapping the Way Forward. 肺癌中的驱动突变--绘制前进之路。
IF 0.6 Q4 ONCOLOGY Pub Date : 2022-12-30 eCollection Date: 2022-07-01 DOI: 10.1055/s-0042-1758549
Arun Chandrasekharan
{"title":"Driver Mutations in Lung Cancer-Mapping the Way Forward.","authors":"Arun Chandrasekharan","doi":"10.1055/s-0042-1758549","DOIUrl":"10.1055/s-0042-1758549","url":null,"abstract":"","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"11 3","pages":"181-182"},"PeriodicalIF":0.6,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/66/48/10-1055-s-0042-1758549.PMC9803547.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10523384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual-Energy X-Ray Absorptiometry and Anthropometry for Assessment of Nutritional Status at Diagnosis in Children with Cancer: A Single-Center Experience from India. 双能x线吸收测量和人体测量用于评估癌症儿童诊断时的营养状况:来自印度的单中心经验。
IF 0.5 Q4 ONCOLOGY Pub Date : 2022-12-02 eCollection Date: 2022-04-01 DOI: 10.1055/s-0042-1757860
Soni Priyanka, Jain Sandeep, Kapoor Gauri, Vishwakarma Gayatri

Gauri KapoorBackground  The survival of children with cancer has improved owing to advances in chemotherapy and better supportive care, and nutritional support is an important component of the latter especially in low- and middle-income countries like India. Materials and Methods  A prospective observational study of 137 newly diagnosed children with cancer aged less than 18 years was planned. Nutritional assessment was done using dual-energy X-ray absorptiometry (DXA), anthropometry, and serum albumin. Patients were followed for 3 months for assessment of treatment-related morbidity. Results  Lean body mass (LBM; DXA), mid-upper arm circumference (MUAC), and body mass index detected undernutrition in 44, 45, and 14% patients, respectively. Combination of arm anthropometry (MUAC and triceps skinfold thickness) with serum albumin categorized patients as adequately nourished (32%), moderately depleted (18%), and severely depleted (49%). Patients with hematological malignancy had a higher prevalence of undernutrition but there was no difference in morbidities between the undernourished and adequately nourished children by any parameter. Hypoalbuminemia observed in 25% patients was associated with significant chemotherapy delays ( p , 0.01) and interval admissions ( p , 0.03). Using LBM as a criterion, linear regression analysis revealed MUAC ( R 2  = 0.681) as the best predictor of undernutrition with lowest standard error. Conclusion  Our study reports undernutrition among two-fifths of newly diagnosed patients of childhood cancer associated with high prevalence of sarcopenia and adiposity. These findings are of utmost clinical relevance in planning interventional strategies.

由于化疗技术的进步和更好的支持性护理,癌症儿童的生存率得到了改善,而营养支持是后者的重要组成部分,特别是在印度等中低收入国家。材料与方法对137例18岁以下新诊断的癌症患儿进行前瞻性观察研究。采用双能x线吸收仪(DXA)、人体测量仪和血清白蛋白进行营养评估。随访3个月,评估治疗相关发病率。结果瘦体重(LBM);DXA)、中上臂围(MUAC)和体重指数分别检测出44.5%、45%和14%的患者营养不良。结合手臂人体测量(MUAC和三头肌皮褶厚度)和血清白蛋白,将患者分为充分营养(32%)、中度营养不足(18%)和严重营养不足(49%)。血液恶性肿瘤患者营养不良的发生率较高,但营养不良儿童和营养充足儿童的发病率在任何参数上都没有差异。25%的患者低白蛋白血症与化疗延迟(p, 0.01)和间隔入院(p, 0.03)相关。以LBM为标准,线性回归分析显示MUAC (r2 = 0.681)是营养不良的最佳预测因子,标准误差最小。结论:我们的研究报告了五分之二的新诊断的儿童癌症患者营养不良与高患病率的肌肉减少症和肥胖相关。这些发现对规划介入策略具有重要的临床意义。
{"title":"Dual-Energy X-Ray Absorptiometry and Anthropometry for Assessment of Nutritional Status at Diagnosis in Children with Cancer: A Single-Center Experience from India.","authors":"Soni Priyanka, Jain Sandeep, Kapoor Gauri, Vishwakarma Gayatri","doi":"10.1055/s-0042-1757860","DOIUrl":"10.1055/s-0042-1757860","url":null,"abstract":"<p><p>Gauri Kapoor<b>Background</b>  The survival of children with cancer has improved owing to advances in chemotherapy and better supportive care, and nutritional support is an important component of the latter especially in low- and middle-income countries like India. <b>Materials and Methods</b>  A prospective observational study of 137 newly diagnosed children with cancer aged less than 18 years was planned. Nutritional assessment was done using dual-energy X-ray absorptiometry (DXA), anthropometry, and serum albumin. Patients were followed for 3 months for assessment of treatment-related morbidity. <b>Results</b>  Lean body mass (LBM; DXA), mid-upper arm circumference (MUAC), and body mass index detected undernutrition in 44, 45, and 14% patients, respectively. Combination of arm anthropometry (MUAC and triceps skinfold thickness) with serum albumin categorized patients as adequately nourished (32%), moderately depleted (18%), and severely depleted (49%). Patients with hematological malignancy had a higher prevalence of undernutrition but there was no difference in morbidities between the undernourished and adequately nourished children by any parameter. Hypoalbuminemia observed in 25% patients was associated with significant chemotherapy delays ( <i>p</i> , 0.01) and interval admissions ( <i>p</i> , 0.03). Using LBM as a criterion, linear regression analysis revealed MUAC ( <i>R</i> <sup>2</sup>  = 0.681) as the best predictor of undernutrition with lowest standard error. <b>Conclusion</b>  Our study reports undernutrition among two-fifths of newly diagnosed patients of childhood cancer associated with high prevalence of sarcopenia and adiposity. These findings are of utmost clinical relevance in planning interventional strategies.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"11 2","pages":"164-171"},"PeriodicalIF":0.5,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10319522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Free Fibula Reconstruction for Bone Tumors Involving Humerus: Our Experience 游离腓骨重建治疗肱骨骨肿瘤的经验
IF 0.5 Q4 ONCOLOGY Pub Date : 2022-11-22 DOI: 10.1055/s-0042-1757438
B. Borthakur, Sumanjit S. Boro, Ashutosh Sahewalla
Abstract Ashutosh Sahewalla Background  Malignant primary bone tumors constitute only 0.2% of all malignancies in adults and approximately 5% of childhood malignancies. The humerus is a common site for malignancies like chondrosarcoma, osteosarcoma, Ewing sarcoma, and metastatic carcinomas. Management consists of multimodality treatment including chemotherapy, radiotherapy, and surgery depending on histology of the tumor and response to therapy. Reconstruction of humerus following oncological resection is a challenging procedure and the surgical options include endoprosthesis, plates, avascular bone grafts, and vascularized autologous bone using microvascular surgery. Materials and Methods  This was a single institutional, retrospective observational study conducted at a tertiary cancer center in Northeast India from June 2018 to March 2020. All the reconstructions were done with free fibular osseous flap. Postoperative outcome was measured with Musculoskeletal Tumor Society (MSTS) scoring. Data was collected from patient records and hospital online reporting system. All data were analyzed using Statistical Package for Social Sciences, version 21. Histograms were used for descriptive statistics; Spearman's correlation was run to determine the relationship between MSTS score and age. Rest of the data was checked with Mann–Whitney and Kruskal–Wallis test. A p -value less than 0.05 was considered as statistically significant at 5% level of significance. Results  Six patients were included in our study ( n  = 6), three of Ewing sarcoma and one each of osteosarcoma, angiosarcoma, and chondrosarcoma. Mean age was 21.7 ± 18.6 years; there was no flap necrosis in the series. One old lady developed nonunion and fracture at the native humerus in follow-up. At the end of 1 year the mean MSTS score of the series was 24.7/30. From data analysis a significant decrease in mean MSTS score was by 0.134 times ( p  = 0.035), been observed with increasing age. The correlation between gender and MSTS score ( p  = 0.325), type of tumor and MSTS score ( p  = 0.490), and location of the tumor and MSTS score ( p  = 0.351) was statistically not significant. Conclusion  Free vascularized fibular graft is an important option for bony reconstruction following tumor resection. In our small series we find it very effective for reconstruction of proximal humerus, particularly in younger patients, when microvascular expertise is present. Following a positive initial experience in humerus reconstruction with free fibular osseus flap a large study population will be considered in near future.
背景:原发性骨恶性肿瘤仅占成人恶性肿瘤的0.2%,约占儿童恶性肿瘤的5%。肱骨是软骨肉瘤、骨肉瘤、尤文氏肉瘤和转移性癌等恶性肿瘤的常见部位。治疗包括多种治疗方式,包括化疗、放疗和手术,取决于肿瘤的组织学和对治疗的反应。肱骨肿瘤切除后的重建是一个具有挑战性的过程,手术选择包括假体、钢板、无血管骨移植物和微血管手术带血管的自体骨。这是一项单一的机构回顾性观察性研究,于2018年6月至2020年3月在印度东北部的一家三级癌症中心进行。所有重建均采用游离腓骨瓣完成。术后结果用肌肉骨骼肿瘤协会(MSTS)评分来衡量。数据收集自患者记录和医院在线报告系统。所有数据均使用社会科学统计软件包第21版进行分析。描述性统计采用直方图;采用Spearman相关法确定MSTS评分与年龄之间的关系。其余数据用Mann-Whitney和Kruskal-Wallis检验。在5%显著性水平下,p值小于0.05被认为具有统计学显著性。结果本研究共纳入6例患者(n = 6),其中尤文氏肉瘤3例,骨肉瘤、血管肉瘤和软骨肉瘤各1例。平均年龄21.7±18.6岁;本组无皮瓣坏死。一位老妇人在随访中出现肱骨不愈合和骨折。在1年结束时,该系列的平均MSTS评分为24.7/30。数据分析显示,随着年龄的增长,平均MSTS评分下降了0.134倍(p = 0.035)。性别与MSTS评分(p = 0.325)、肿瘤类型与MSTS评分(p = 0.490)、肿瘤部位与MSTS评分(p = 0.351)的相关性均无统计学意义。结论游离带血管腓骨移植是肿瘤切除后骨重建的重要选择。在我们的小系列中,我们发现它对肱骨近端重建非常有效,特别是在年轻患者中,当微血管专家在场时。随着游离腓骨瓣肱骨重建的初步积极经验,在不久的将来将考虑更大的研究人群。
{"title":"Free Fibula Reconstruction for Bone Tumors Involving Humerus: Our Experience","authors":"B. Borthakur, Sumanjit S. Boro, Ashutosh Sahewalla","doi":"10.1055/s-0042-1757438","DOIUrl":"https://doi.org/10.1055/s-0042-1757438","url":null,"abstract":"Abstract Ashutosh Sahewalla Background  Malignant primary bone tumors constitute only 0.2% of all malignancies in adults and approximately 5% of childhood malignancies. The humerus is a common site for malignancies like chondrosarcoma, osteosarcoma, Ewing sarcoma, and metastatic carcinomas. Management consists of multimodality treatment including chemotherapy, radiotherapy, and surgery depending on histology of the tumor and response to therapy. Reconstruction of humerus following oncological resection is a challenging procedure and the surgical options include endoprosthesis, plates, avascular bone grafts, and vascularized autologous bone using microvascular surgery. Materials and Methods  This was a single institutional, retrospective observational study conducted at a tertiary cancer center in Northeast India from June 2018 to March 2020. All the reconstructions were done with free fibular osseous flap. Postoperative outcome was measured with Musculoskeletal Tumor Society (MSTS) scoring. Data was collected from patient records and hospital online reporting system. All data were analyzed using Statistical Package for Social Sciences, version 21. Histograms were used for descriptive statistics; Spearman's correlation was run to determine the relationship between MSTS score and age. Rest of the data was checked with Mann–Whitney and Kruskal–Wallis test. A p -value less than 0.05 was considered as statistically significant at 5% level of significance. Results  Six patients were included in our study ( n  = 6), three of Ewing sarcoma and one each of osteosarcoma, angiosarcoma, and chondrosarcoma. Mean age was 21.7 ± 18.6 years; there was no flap necrosis in the series. One old lady developed nonunion and fracture at the native humerus in follow-up. At the end of 1 year the mean MSTS score of the series was 24.7/30. From data analysis a significant decrease in mean MSTS score was by 0.134 times ( p  = 0.035), been observed with increasing age. The correlation between gender and MSTS score ( p  = 0.325), type of tumor and MSTS score ( p  = 0.490), and location of the tumor and MSTS score ( p  = 0.351) was statistically not significant. Conclusion  Free vascularized fibular graft is an important option for bony reconstruction following tumor resection. In our small series we find it very effective for reconstruction of proximal humerus, particularly in younger patients, when microvascular expertise is present. Following a positive initial experience in humerus reconstruction with free fibular osseus flap a large study population will be considered in near future.","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44863677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large Symptomatic Sclerosing Pneumocytoma in a Young Male Smoker-A Rare and Deceptive Presentation. 年轻男性吸烟者的大症状性硬化性肺细胞瘤-一种罕见且具有欺骗性的表现。
IF 0.5 Q4 ONCOLOGY Pub Date : 2022-10-01 DOI: 10.1055/s-0042-1751029
Sunil Pasricha, Divya Bansal, Ullas Batra, Ankush Jajodia, Venkata Pradeep Babu Koyyala, Anurag Mehta
Pulmonary sclerosing pneumocyto__ma (PSP) is a rare pulmonary tumor that behaves in a benign fashion and has excellent prognosis. 1 The tumor was historically termed as sclerosing hemangioma by Liebow and Hubbell in 1956.
{"title":"Large Symptomatic Sclerosing Pneumocytoma in a Young Male Smoker-A Rare and Deceptive Presentation.","authors":"Sunil Pasricha,&nbsp;Divya Bansal,&nbsp;Ullas Batra,&nbsp;Ankush Jajodia,&nbsp;Venkata Pradeep Babu Koyyala,&nbsp;Anurag Mehta","doi":"10.1055/s-0042-1751029","DOIUrl":"https://doi.org/10.1055/s-0042-1751029","url":null,"abstract":"Pulmonary sclerosing pneumocyto__ma (PSP) is a rare pulmonary tumor that behaves in a benign fashion and has excellent prognosis. 1 The tumor was historically termed as sclerosing hemangioma by Liebow and Hubbell in 1956.","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"11 4","pages":"378-381"},"PeriodicalIF":0.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/f0/10-1055-s-0042-1751029.PMC9902086.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10681643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
South Asian Journal of Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1